Tag:
NanoTherapies
Latest Headlines
Latest Headlines
Cancer Therapeutics ups stake in NanoTherapies
Cancer Therapeutics, has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, giving Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.
Cancer Therapeutics takes a stake in NanoTherapies
Utah-based Cancer Therapeutics has taken a 25 percent stake in NanoTherapies, a company that's developing therapies for cancer treatment based on calcium phosphate nanoparticles for therapeutic and
